Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)
Not Applicable
Completed
- Conditions
- Osteoporosis
- Registration Number
- NCT00139438
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test and percent appropriately prescribed a medication for osteoporosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4266
Inclusion Criteria
- Members of the Horizon Blue Cross Blue Shield of New Jersey who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).
Exclusion Criteria
- Individuals who are not members of Horizon Blue Cross Blue Shield of New Jersey and who otherwise do not meet the inclusion criteria.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method A composite measure of bone mineral density (BMD) testing and/or osteoporosis medications prescriptions.
- Secondary Outcome Measures
Name Time Method BMD testing, osteoporosis medication prescriptions, fracture